Bernstein Lab / Epigenetics

Epigenetics

Daniel Solvie, PhD

Daniel joined the Bernstein Lab as a research fellow in November 2023. He completed his PhD in the lab of Martin Eilers at JMU Wuerzburg in Germany, studying the molecular mechanisms of the oncoprotein MYC as a stress resilience factor.

Daniel Fridman

Daniel is a PhD student in BIG (Bioinformatics and Integrative Genomics) at Harvard Medical School. He is interested in applying computational biology to study gene regulation. He joined the Bernstein lab in June 2023 and is working with Justin Becker to study the regulation of transposable elements in cancer using long-read Nanopore sequencing technology.

Tyler Miller, MD, PhD

Ty is a Clinical Pathology resident at MGH and joined the lab as a research fellow in 2019. He studies the tumor microenvironment in glioblastoma to discover novel ways to target tumor cells. He is currently profiling cellular states of both normal and neoplastic cells in glioblastoma tumors to identify ways to harness the immune … Continued

Eugenio Mattei, PhD

Computational Scientist with a background in computer engineering working on the characterization of transposable elements in healthy cells and cancer. Interested in robust statistical approaches to analyze data from single-cell experiments. ORCID: https://orcid.org/0000-0002-8889-658X LinkedIn: https://www.linkedin.com/in/eugeniomattei/ @eugmattei

Chadi El Farran, PhD

Chadi El Farran is a Lebanese national who joined the lab as a Research Fellow. Chadi is interested in deciphering the cell-cell communication patterns that define the fate and function of these cells. He is also keen on studying the epigenetic and transcriptomic changes which are associated with diseases.